Skip to Main Content

Paper Details

MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.
Clin Cancer Res
100
2015
AKT, BRAF, BRAF mutations, EGFR, EGFR-mutant, ERBB2, ERK, HER2, K57N, KRAS, LAD, LADs, Lung Adenocarcinoma, MAP2K1, MAPK, MEK, MEK1, MEK1 mutations, NRAS, PIK3CA, Q56P, Tumors, cancer, lung adenocarcinoma, lung cancers, patient, patients
Author NameAffiliation
Alexander DrilonMemorial Sloan Kettering Cancer Center, and Weill Cornell Medical College
Boris RevaMemorial Sloan Kettering Cancer Center
Boris RevaMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2